Fenoldopam administration is via a continuous intravenous (IV) infusion using an infusion pump.

**Available Formulations**

- Generic: 10 mcg/mL (1 mL); 20 mg/2 mL (2 mL)

**Adult Dosing**

**Severe/Malignant Hypertension**

- Initiate treatment at 0.01 to 0.3 mcg/kg/minute then increase by 0.05 to 0.1 mcg/kg/minute at 15 minute intervals until desired blood pressure is reached or a max of 1.6 mcg/kg/minute is reached.

- Renal impairment dosing: No adjustments

- Hepatic impairment dosing: No adjustments

**Pediatric Dosing**

**Severe Hypertension**

- Initiate treatment at 0.2 mcg/kg/minute then increases by 0.3 to 0.5 mcg/kg/minute at 20 to 30 minute intervals until target blood pressure is reached or until a max of 0.8 mcg/kg/minute is reached.

- Pediatric renal impairment dosing: No adjustments

- Pediatric hepatic impairment dosing: No adjustments

**Neonatal Dosing**(Full-term or at least 2 kg)

**Severe Hypertension**

- Initiate treatment at 0.2 mcg/kg/minute then increases by 0.3 to 0.5 mcg/kg/minute at 20 to 30 minute intervals until target blood pressure is reached or until reaching a max of 0.8 mcg/kg/minute.

**Pharmacokinetics**

- The onset of action is 10 minutes in adults and 5 minutes in children. The half-life of fenoldopam is 5 minutes in adults and 3 to 5 minutes in children. Metabolization is by the liver, and excretion is primarily in the urine. The volume of distribution is 0.6 L/kg, and the duration is 1 hour.